gp96: Clinical Trials

5 trials of gp96, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 withdrawn. 3 Phase 1, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Withdrawn 1
Phase 23Unknown 2, Completed 1
Phase 31Unknown 1

Follow gp96: new trials by email Literature Review of gp96 trials Research Report on gp96

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer
gp96 - Liver Cancer
Phase 2 / Phase 3UnknownCure&Sure Biotech Co., LTD802019-12-192019-12-20
A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
gp96, Temozolomide, radiotherapy - Glioma of Brain
Phase 2UnknownCure&Sure Biotech Co., LTD1502019-08-212020-03-12
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
gp96-Ig Vaccine, Theophylline, Oxygen - Non-Small Cell Lung Cancer, Non-small-cell Lung Carcinoma
Phase 1WithdrawnEckhard Podack2014-12-012014-11-17
Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
gp96 - Glioma
Phase 1CompletedCure&Sure Biotech Co., LTD202013-07-012017-11-17
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors
Phase 1 / Phase 2CompletedUniversity of California, San Francisco962005-11-182021-05-13

Conditions studied

Brain Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Central Nervous System Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)

Sponsors

Cure&Sure Biotech Co., LTD (3)  ·  Eckhard Podack (1)  ·  University of California, San Francisco (1)

Countries

China (2)  ·  United States (1)

Top investigators

Ikechukwu Akunyili, MD (1)  ·  Jennifer Clarke, MD (1)  ·  Zhixian Gao, Doctor (1)

Results publications

PMID 24335700, PMID 29769450

NIH funding

P50CA097257 (1), R01CA164714 (1)